期刊文献+

体重指数影响骨钙素基因HindⅢ多态性与中国绝经前妇女空腹血糖间的关联

Association between HindⅢ RFLP of the osteocalcin gene and fast plasma glucose level in premenopausal Chinese women:can be modified by body mass index
下载PDF
导出
摘要 目的:考察骨钙素(BGP)Hind III基因多态性是否与中国绝经前妇女空腹血糖(FPG)变异间存在关联;检测BGP基因型和体重指数(BMI)间的关联是否可以部分地解释BGP基因型与FPG间的关联。方法:研究对象是328名中国绝经前妇女,年龄21岁以上[(33.2±5.9)岁],FPG值平均为4.92 mmol/L(标准差,0.81),采用聚合酶链反应(PCR)-限制性片段长度多态(RFLP)法对所有研究对象的BGP Hind III位点进行基因分型。结果:BGP Hind III多态性与校正年龄的FPG以及未用年龄校正的FPG间均存在显著的关联(P值分别为0.028和0.041),且BGP基因可以解释3.32%的FPG变异。但BGP Hind III多态性与年龄和BMI校正的FPG间无显著关联(P=0.517)。此外,BGP Hind III多态性与未校正的BMI(P=0.002)或年龄校正的BMI(P=0.003)都有显著的关联,且BMI与未校正的FPG也存在显著相关(r=0.424,P<0.01),BMI可以解释20.15%的FPG变异。结论:BMI可影响BGP Hind III多态性与中国绝经前妇女FPG间的关联。该研究结果提示协变量如BMI在FPG的遗传关联研究中的重要性。 AIM: To investigate whether osteocalcin( BGP) Hind III genetic polymorphism is associated with fasting plasma glucose( FPG) variation in premenopausal Chinese women; and to test the hypothesis that the association between BGP genotypes and FPG may be partially accounted for by an association between BGP genotypes and BMI.METHODS: The study subjects were 328 unrelated premenopausal Chinese women aged 21 years and over [( 33. 2 ± 5. 9) years],with an average FPG of4. 92 mmol / L( SD,0. 81). All subjects were genotyped at the BGP Hind III loci using polymerase chain reaction( PCR)-restriction fragment length polymorphism( RFLP). RESULTS: Raw FPG was significantly associated with BGP Hind III polymorphism with and without adjusting for age( P = 0. 028 and 0. 041,respectively). This genetic effect can explain 3. 22% of FPG variation. However,no significant association was found between BGP Hind III polymorphism and FPG adjusted by both age and body mass index( BMI)( P = 0. 517). In addition,we observed a significant association between BGP Hind III polymorphism with unadjusted BMI( P =0. 002) or BMI adjusted for age( P = 0. 003). The raw FPG was also found to be significantly correlated with BMI( r = 0. 424; P〈 0. 01),with BMI explaining 20. 15% of the variation of FPG. CONCLUSION: BMI may modify the association between the Hind III polymorphism of the BGP gene and FPG in premenopausal Chinese women,which highlights the importance of incorporating covariates such as BMI into genetic association studies of FPG.
出处 《中国临床药理学与治疗学》 CAS CSCD 2015年第9期1026-1031,共6页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 国家自然科学基金项目(81302501 81560529) 江西省自然科学基金(20151BBG70249 20132BAB215005 20122BAB215005) 江西省教育厅基金(GJJ14093 GJJ12149) 江西省卫生计生委科技计划项目(20155643) 南昌大学省级创新创业训练计划(201410403132) 科研训练项目(14001840)
关键词 空腹血糖(FPG) 体重指数(BMI) 骨钙素(BGP)基因 遗传关联 fasting plasma glucose(FPG) body mass index(BMI) osteocalcin(BGP) gene genetic association
  • 相关文献

参考文献4

二级参考文献70

  • 1顾永辉,刘超,武晓泓,刘翠萍,覃又文.血糖控制对初发2型糖尿病患者C-反应蛋白及白细胞介素6水平的影响[J].中国临床康复,2006,10(44):63-65. 被引量:8
  • 2陈碧莲,刘慧霞,潘瑞喆.葡萄糖耐量减低患者二甲双胍干预治疗的临床效果[J].中国临床药理学与治疗学,2007,12(1):107-110. 被引量:7
  • 3Ong CR, Molyneaux LM, Constanino MI, et al. Long-term efficacy of metformin therapy in nonobese individuals with type 2 diabetes[J]. Diabetes Care, 2006,29(11) :2361-2364.
  • 4American Diabetes Association. Standards of medical care in diabetes[J]. Diabetes Care, 2008, 31 (Suppl 1) : S12-S54.
  • 5UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes ( UKPDS33 ) [ J ]. Lancet, 1998, 352 (9178) :837-853.
  • 6Mamputu JC, Wiernsperger N, Renier G. Metformin inhibits monocyte adhesion to endothelial cells and foam cell formation: potential implications for diabetic vascular diseases [J]. Br J Diabetes Vasc Dis, 2003, 3(4): 302-310.
  • 7Ling Li, Jean-Claude Mamputu, Nicolas Wiernsperger, et al. Signaling pathways involved in human vascular smooth muscle cell proliferation and matrix metalloproteinase-2 expression induced by leptin[J]. Diabetes, 2005,54(7) :2227-2234.
  • 8Wiernsperger NF. Metformin: intrinsic vasculoprotective properties [J]. Diabetes Technol Therap, 2000, 2(2): 259-272.
  • 9Mamputu JC, Wiernsperger NF, Renier G. Antiatherogenic properties of metformin: the experimental evidence [J]. Diabetes Metab, 2003, 29(4): 6S71-6S76.
  • 10Weichert W, Breddin HK. Antithrombotic effects of metformin in laser injured arteries[J]. Diabetes Metab, 1988, 14(4) :540-543.

共引文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部